促性腺激素释放激素激动剂与人绒毛膜促性腺激素触发周期的整倍体率比较
这项回顾性队列研究纳入366例患者共539个采用胚胎植入前非整倍体检测(PGT-A)的IVF周期,比较GnRH激动剂(GnRHa)与hCG触发后的整倍体率。GnRHa组每活检胚胎整倍体率较高(37.8%±2.1% vs 30.3%±1.8%),但多变量回归校正混杂因素后两组无差异,每获卵整倍体率亦无显著差异。结论认为两种触发方式的整倍体率相当。
要点
- GnRHa组每活检胚胎整倍体率37.8%±2.1%,高于hCG组的30.3%±1.8%。
- 多变量回归校正混杂因素后,两组整倍体率无差异。
- 每获卵整倍体率两组无显著差异(33.9%±2.2% vs 28.0%±1.9%)。
核心结论
- GnRHa与hCG触发获得相当的整倍体率。
- 鉴于GnRHa的有效性和已知的安全性提升,在全胚冷冻PGT-A周期中应将其视为有效的触发选择。
研究设计与样本
- 回顾性队列研究,地点为大学附属生殖中心。
- 共纳入366例患者、539个采用PGT-A的IVF周期。
- 干预为使用GnRHa或hCG触发卵母细胞成熟。
主要发现
- GnRHa触发组患者更年轻、体重指数更低、抗苗勒管激素水平更高,获卵数和活检胚胎数更多。
- 每活检胚胎整倍体率GnRHa组为37.8%±2.1%,hCG组为30.3%±1.8%。
- 多变量回归分析控制潜在混杂因素后,两组间未见差异。
- 每获卵整倍体率总体无显著差异:GnRHa组33.9%±2.2% vs hCG组28.0%±1.9%。
- 按年龄分层并控制PGT-A检测方式后,两组间无显著差异。
关键数值与推荐
- 每获卵整倍体率随年龄下降:<35岁为15.8%±1.2%,≥41岁为4.3%±0.9%。
临床怎么用
- 作者认为,鉴于GnRHa展示的有效性和已知的安全性提升,在全胚冷冻PGT-A周期中应将其视为有效的触发选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate differences in euploidy rates between IVF cycles triggered with either GnRH agonist (GnRHa) or hCG. DESIGN: Retrospective cohort study. SETTING: University-affiliated fertility center. PATIENT(S): A total of 366 patients performing 539 IVF cycles utilizing preimplantation genetic testing for aneuploidy (PGT-A). INTERVENTION(S): Gonadotropin-releasing hormone agonist or hCG trigger of oocyte maturation during IVF cycles. MAIN OUTCOME MEASURE(S): Rate of euploid embryos. RESULT(S): Patients in the GnRHa trigger arm were younger, with a lower body mass index and higher antimüllerian hormone level, and they had a higher number of oocytes retrieved and embryos biopsied. Euploid rate per embryo biopsied was higher after GnRHa trigger than after hCG trigger (37.8% ± 2.1% vs. 30.3% ± 1.8%), but multivariate regression analysis controlling for potential confounding factors did not show any differences between the two groups. Moreover, the euploid rate per oocyte retrieved was not significantly different overall (GnRHa vs. hCG: 33.9% ± 2.2% vs. 28.0% ± 1.9%). The anticipated decline in the rate of euploid embryos per oocyte retrieved went from 15.8% ± 1.2% for age <35 years to 4.3% ± 0.9% for patients aged ≥41 years. There were no significant differences between the two groups after stratifying by age and controlling for PGT-A testing modality. CONCLUSION(S): Both GnRHa and hCG trigger result in comparable euploid rates. Trigger with GnRHa should therefore be considered a valid option for trigger modality in freeze-all PGT-A cycles, in view of its demonstrated effectiveness and known safety enhancement.
引用
- Thorne J, Loza A, Kaye L, et al. Euploidy rates between cycles triggered with gonadotropin-releasing hormone agonist and human chorionic gonadotropin. Fertil Steril. 2019. PMID: 31103285. doi:10.1016/j.fertnstert.2019.03.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。